Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression

被引:31
作者
Dietrich, DE
Hauser, U
Peters, M
Zhang, YY
Wiesmann, M
Hasselmann, M
Rudolf, S
Jüngling, O
Kirchner, H
Münte, TF
Arolt, V
Emrich, HM
Johannes, S
Rothermundt, M
机构
[1] Hannover Med Sch, Dept Clin Psychiat & Psychotherapy, D-3000 Hannover, Germany
[2] Univ Munster, Dept Psychiat, D-4400 Munster, Germany
[3] Med Univ Lubeck, Dept Neuroradiol, D-23538 Lubeck, Germany
[4] Med Univ Lubeck, Inst Immunol & Transfus Med, D-23538 Lubeck, Germany
[5] Otto Von Guericke Univ, Dept Neurophysiol, Magdeburg, Germany
[6] Clin Neurorehabil Bellikon, Bellikon, Switzerland
关键词
depression; S100B; attention; target evaluation; inhibition processes; event-related potentials; N2; P3b;
D O I
10.1016/j.neulet.2003.09.062
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Selective attention processes (N2 and P3 components of event-related potentials (ERPs)) have been shown to be impaired in depressed patients but findings have been mixed. Part of this variability might be explained by neurobiological factors. ERPs (Go/Nogo paradigm) were investigated in patients with remitted major depression in relation to S100B. S100B, an astroglial protein with neuroplastic properties, has been shown to be increased in depression. Its pathophysiologic role in depression, however, is not yet sufficiently understood. Patients with increased S 10013 serum levels (n = 6) showed a normal N2- and P3-amplitude in contrast to a reduced N2- and P3-amplitude in patients with normal S100B serum levels (n = 6). These findings provide evidence of a correlation between S100B levels and attentional processes in patients with recurrent depression and further substantiate S100B's role as a marker in the course of affective disorders. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 20 条
  • [1] PLANNING CONTROLLED CLINICAL-TRIALS ON THE BASIS OF DESCRIPTIVE DATA-ANALYSIS
    ABT, K
    [J]. STATISTICS IN MEDICINE, 1991, 10 (05) : 777 - 795
  • [2] [Anonymous], HDB AFFECTIVE DISORD
  • [3] S100B and response to treatment in major depression: a pilot study
    Arolt, V
    Peters, M
    Erfurth, A
    Wiesmann, M
    Missler, U
    Rudolf, S
    Kirchner, H
    Rothermundt, M
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 (04) : 235 - 239
  • [4] Visual cognitive dysfunction in depression: an event-related potential study
    Bange, F
    Bathien, N
    [J]. EVOKED POTENTIALS-ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1998, 108 (05): : 472 - 481
  • [5] PERCEPTUAL AND PHYSIOLOGICAL DYSFUNCTION IN DEPRESSION
    BLACKBURN, IM
    ROXBOROUGH, HM
    MUIR, WJ
    GLABUS, M
    BLACKWOOD, DHR
    [J]. PSYCHOLOGICAL MEDICINE, 1990, 20 (01) : 95 - 103
  • [6] DEPRESSION AND MEMORY IMPAIRMENT - A METAANALYSIS OF THE ASSOCIATION, ITS PATTERN, AND SPECIFICITY
    BURT, DB
    ZEMBAR, MJ
    NIEDEREHE, G
    [J]. PSYCHOLOGICAL BULLETIN, 1995, 117 (02) : 285 - 305
  • [7] DIETRICH DE, 2004, IN PRESS PSYCHIAT RE
  • [8] S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles
    Donato, R
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (07) : 637 - 668
  • [9] Neurotrophic factor S100beta in major depression
    Grabe, HJ
    Ahrens, N
    Rose, HJ
    Kessler, C
    Freyberger, HJ
    [J]. NEUROPSYCHOBIOLOGY, 2001, 44 (02) : 88 - 90
  • [10] RELATION OF A NEGATIVE ERP COMPONENT TO RESPONSE-INHIBITION IN A GO/NO-GO TASK
    JODO, E
    KAYAMA, Y
    [J]. ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1992, 82 (06): : 477 - 482